Recursion Pharmaceuticals, Inc. (RXRX) Revenue History
Recursion Pharmaceuticals, Inc. (RXRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $10.18M |
| 2022-12-31 | $39.84M |
| 2023-12-31 | $44.58M |
| 2024-12-31 | $58.84M |
| 2025-12-31 | $74.68M |
How RXRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | $66.80M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
These are five companies in the same sector as RXRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Recursion Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("RXRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RXRX | $3.50 | +4.79% | 22.90M |
| 3 | ||||
| 4 | ||||
| 5 |